AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Viqugim-M 2mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Sanify Healthcare Pvt Ltd

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Viqugim-M 2mg/500mg Tablet

Diabex Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabex Duo should be taken with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar readings. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical supervision can elevate glucose levels, risking complications like kidney impairment, vision loss, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan incorporating a healthy diet, regular exercise, and weight management, as guided by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a common side effect, manifested by symptoms like sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Additional possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should seek medical advice before use. Regular blood glucose monitoring is necessary, along with potential blood tests to track blood cell counts and liver function.

Primary Ingredients of Viqugim-M 2mg/500mg Tablet

No text was provided to rewrite. Please provide the text you would like me to rephrase.

Uses of Viqugim-M 2mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Viqugim-M 2mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Viqugim-M 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing. It should be administered with a meal.

Common Side effects of Viqugim-M 2mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Viqugim-M 2mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the entire tablet; do not chew, crush, or fracture it. Viqugim-M 2mg/500mg tablets should be administered with food.

How Viqugim-M 2mg/500mg Tablet works:

Viqugim-M 2mg/500mg tablets contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Viqugim-M 2mg/500mg tablets with alcohol is not advisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Viqugim-M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Consult your doctor for guidance.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Viqugim-M 2mg/500mg tablets due to potential infant toxicity.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Viqugim-M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. Viqugim-M 2mg/500mg tablets are contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Viqugim-M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consult a physician. For those with mild to moderate hepatic dysfunction, initiate treatment with a reduced Viqugim-M 2mg/500mg tablet dosage; however, it's contraindicated in patients with severe liver disease.

What if you forget to take Viqugim-M 2mg/500mg Tablet :

Should you forget a Viqugim-M 2mg/500mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Viqugim-M 2mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Viqugim-M 2mg/500mg Tablet

Store this medication in its original, tightly closed container, following the instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Viqugim-M 2mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Seek immediate medical attention, including discontinuing Viqugim-M, if these symptoms occur.
Viqugim-M 2mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Viqugim-M 2mg/500mg tablets may cause common side effects such as hypoglycemia, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Viqugim-M 2mg/500mg Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, supplemental vitamin B12 is recommended at least annually, according to some researchers.
Viqugim-M 2mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Viqugim-M 2mg/500mg Tablet with alcohol is unsafe. This combination may cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Viqugim-M 2mg/500mg Table...
43
MRP 50
13% off